| Literature DB >> 36232218 |
Kotaro Hirakawa1, Atsuko Nakayama2, Masakazu Saitoh3, Kentaro Hori1, Tomoki Shimokawa4, Tomohiro Iwakura4, Go Haraguchi5, Mitsuaki Isobe6.
Abstract
The in-hospital mortality rate among patients after surgery for acute type A aortic dissection (ATAAD) has improved chronologically. However, the relationship between the incidence of hospitalisation-associated disability (HAD) and acute cardiac rehabilitation in patients after surgery for ATAAD has not been reported. Therefore, this study evaluated factors related to HAD in patients after surgery for ATAAD. This single-centre retrospective observational study included 483 patients who required emergency surgery for ATAAD. HAD occurred in 104 (21.5%) patients following cardiovascular surgery. Factors associated with HAD were age (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.02-1.09; p = 0.001), noninvasive positive pressure ventilation (NPPV; OR, 2.15; 95% CI, 1.10-4.19; p = 0.025), postoperative delirium (OR, 2.93; 95% CI, 1.60-5.37; p = 0.001), and timing of walking onset (OR, 1.29; 95% CI, 1.07-1.56; p = 0.008). Furthermore, a late walking onset was associated with a higher risk of developing HAD and more severe functional decline. Early rehabilitation based on appropriate criteria has possibility of preventing HAD.Entities:
Keywords: acute type A aortic dissection; emergency surgery; hospitalisation-associated disability; rehabilitation
Mesh:
Year: 2022 PMID: 36232218 PMCID: PMC9566428 DOI: 10.3390/ijerph191912918
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Schematic presentation of the study procedure. This study included 483 patients who required emergency surgery for ATAAD. ATAAD, acute type A aortic dissection; ADL, activities of daily living; HAD, mobilization on-associated disability.
Clinical characteristics.
| Overall | Non-HAD | HAD | ||
|---|---|---|---|---|
| ( | ( | ( | ||
| Age, years | 69 (59–78) | 68 (58–75) | 78 (66–83) | <0.001 |
| Female, | 250 (51.8) | 187 (49.3) | 63 (60.6) | <0.05 |
| BMI, kg/m2 | 23.6 (21.3–26.3) | 23.7 (21.4–26.4) | 23.1 (21.2–26.0) | 0.62 |
| Comorbidity, | ||||
| Hypertension | 336 (69.6) | 260 (68.6) | 76 (73.1) | 0.38 |
| Dyslipidaemia | 93 (19.3) | 71 (18.7) | 22 (21.2) | 0.58 |
| Diabetes | 25 (5.2) | 17 (4.5) | 8 (7.7) | 0.19 |
| Chronic kidney disease | 24 (5.0) | 17 (4.5) | 7 (6.7) | 0.35 |
| Coronary artery disease | 21 (4.3) | 16 (4.2) | 5 (4.8) | 0.49 |
| Chronic obstructive pulmonary disease | 8 (1.7) | 6 (1.6) | 2 (1.9) | 0.54 |
| Blood biochemistry | ||||
| Haemoglobin, g/dL | 12.3 (11.1–13.8) | 12.5 (11.2–14.0) | 11.6 (10.2–12.7) | <0.001 |
| Platelet, 103/μL | 164 (132–200) | 165 (132–202) | 161 (133–194) | 0.53 |
| Creatinine, mg/dL | 0.87 (0.70–1.12) | 0.86 (0.69–1.12) | 0.91 (0.75–1.13) | 0.15 |
| Albumin, g/dL | 3.6 (3.3–4.0) | 3.7 (3.4–4.0) | 3.4 (3.0–3.7) | <0.001 |
| CRP, mg/dL | 0.15 (0.04–0.99) | 0.13 (0.04–0.90) | 0.18 (0.05–1.40) | 0.38 |
| Aortic surgery, | 0.40 | |||
| Ascending aortic replacement | 255 (51.6) | 187 (49.2) | 68 (59.6) | |
| Hemi arch replacement | 26 (5.3) | 18 (4.7) | 8 (7.0) | |
| Total arch replacement | 135 (27.3) | 112 (29.5) | 23 (20.2) | |
| Concomitant | 78 (15.8) | 63 (16.6) | 15 (13.2) | |
| Operation time, min | 225 (185–287) | 225 (182–285) | 229 (193–304) | 0.21 |
| Cardiopulmonary bypass time, min | 128 (105–168) | 128 (104–168) | 128 (110–169) | 0.54 |
| Circulatory arrest time, min | 27 (22–38) | 27 (21–39) | 28 (23–38) | 0.42 |
| IMV time, h | 22.9 (18.2–34.6) | 22.1 (17.7–30.9) | 31.6 (21.8–46.3) | <0.001 |
| Bleeding, ml | 220 (150–350) | 210 (150–320) | 250 (163–438) | <0.05 |
| APACHE II score, points | 15 (12–18) | 15 (12–18) | 16 (13–18) | <0.05 |
| NPPV, | 102 (21.1) | 67 (17.7) | 35 (33.7) | <0.001 |
| CRRT, | 12 (2.5) | 6 (1.6) | 6 (5.8) | <0.05 |
| Acute kidney injury, | 175 (36.2) | 130 (34.3) | 45 (43.3) | 0.09 |
| Delirium, | 123 (25.5) | 71 (18.7) | 52 (50.0) | <0.001 |
| Distal enlargement, | 34 (7.0) | 26 (6.7) | 8 (7.7) | 0.77 |
| ICU stay, days | 3 (2–5) | 3 (2–4) | 4 (3–7) | <0.001 |
| Hospital stay, days | 14 (11–21) | 14 (11–21) | 13 (10–22) | 0.50 |
| Cardiac rehabilitation, days | ||||
| Sitting | 2 (1–2) | 2 (1–2) | 2 (2–3) | <0.001 |
| Standing | 2 (1–3) | 2 (1–2) | 2 (2–3) | <0.001 |
| Walking | 3 (3–4) | 3 (2–4) | 5 (3–7) | <0.001 |
| Barthel index, points | ||||
| Preoperative | 100 (100–100) | 100 (100–100) | 100 (100–100) | 0.40 |
| Discharge | 100 (100–100) | 100 (100–100) | 80 (55–90) | <0.001 |
| Home discharge, | 276 (57.1) | 255 (67.3) | 21 (20.2) | <0.001 |
BMI, body mass index; CRP, C-reactive protein; IMV, invasive mechanical ventilation; APACHE, Acute Physiology and Chronic Health Evaluation; NPPV, noninvasive positive pressure ventilation; CRRT, continuous renal replacement therapy; ICU, intensive care unit.
Noncompletion of early mobilisation.
| Not awakening | 51 (38.9) |
| Respiratory-related | 26 (19.8) |
| Sedation | 14 (10.7) |
| Uncontrolled blood pressure | 10 (7.6) |
| Arrhythmia | 8 (6.1) |
| Acute kidney injury | 6 (4.6) |
| Pain distress | 5 (3.8) |
| Active bleeding | 4 (3.1) |
| Acute limb ischemia | 2 (1.5) |
| Others | 5 (3.8) |
Clinical characteristics according to walking onset category.
| Walking Onset Category | |||
|---|---|---|---|
| Early | Usual | Delayed | |
| ( | ( | ( | |
| Age, years | 66 (55–75) | 71 (62–79) 1 | 69 (57–81) |
| Female, | 48 (43.2) | 137 (56.4) | 65 (50.4) |
| BMI, kg/m2 | 23.4 (21.3–25.6) | 23.7 (21.5–26.4) | 23.1 (20.9–26.6) |
| Comorbidity, | |||
| Hypertension | 79 (71.2) | 170 (70.0) | 87 (67.4) |
| Dyslipidemia | 22 (19.8) | 50 (20.6) | 21 (16.3) |
| Diabetes | 4 (3.6) | 15 (6.2) | 6 (4.7) |
| Chronic kidney disease | 3 (2.7) | 11 (4.5) | 10 (7.8) |
| Coronary artery disease | 2 (1.8) | 12 (4.9) | 7 (5.4) |
| Chronic obstructive pulmonary disease | 3 (2.7) | 3 (1.2) | 2 (1.6) |
| Operation time, min | 215 (184–280) | 218 (180–268) | 263 (197–324) 1,2 |
| Cardiopulmonary bypass time, min | 123 (102–165) | 125 (103–157) | 149 (110–192) 1,2 |
| IMV time, h | 19.3 (16.4–23.7) | 22.6 (18.0–30.5) 1 | 38.1 (22.2–50.7) 1,2 |
| Bleeding, ml | 200 (130–270) | 220 (150–350) | 280 (165–453) 1,2 |
| APACHE II score, points | 14 (12–17) | 15 (13–17) | 15 (13–19) 1 |
| NPPV, | 8 (7.2) | 42 (17.3) | 52 (40.3) 3 |
| CRRT, | 1 (0.9) | 2 (0.8) | 9 (7.0) 3 |
| Delirium, | 11 (9.9) | 58 (23.9) | 54 (41.9) 3 |
| ICU stay, days | 2 (1–2) | 3 (2–3) 1 | 5 (4–8) 1,2 |
| Hospital stay, days | 13 (10–18) | 14 (11–20) | 19 (13–28) 1,2 |
| Preoperative BI, points | 100 (100–100) | 100 (100–100) | 100 (100–100) |
1p < 0.05 vs. Early, 2 p < 0.05 vs. Usually, 3 p < 0.05 vs. χ2 test. BMI, body mass index; IMV, invasive mechanical ventilation; APACHE, Acute Physiology and Chronic Health Evaluation; NPPV, noninvasive positive pressure ventilation; CRRT, continuous renal replacement therapy; ICU, intensive care unit; BI, Barthel index.
Figure 2Subitems of reduced BI scores in patients with HAD (n = 104). Patients with declines in multiple subitems were included. BI: Barthel Index.
Figure 3Barthel Index change by the walking start category. The decrease of −5 points was 33% in the early-start walking group, 44% in the usual-start walking group, and 20% in the delayed-start walking group; the decrease of −20 to −10 points was 44%, 33%, and 19%, respectively; and the decrease of −25 points or more was 22%, 22%, and 61%, respectively.
Univariate and multivariate analyses for hospitalisation-associated disability.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Age [every 1-year increase] | 1.05 | 1.03–1.08 | <0.001 | 1.05 | 1.02–1.09 | <0.01 |
| <60 years | 1.00 | 1.00 | ||||
| 60–69 years | 0.75 | 0.36–1.57 | 0.45 | |||
| 70–79 years | 1.38 | 0.71–2.67 | 0.35 | |||
| ≥80 years | 4.83 | 2.56–9.12 | <0.001 | 4.28 | 1.62–11.35 | <0.01 |
| Female | 1.58 | 1.01–2.45 | <0.05 | |||
| Albumin [every 1 g/dL increase] | 0.37 | 0.23–0.58 | <0.001 | |||
| Haemoglobin [every 1 g/dL increase] | 0.76 | 0.67–0.86 | <0.001 | |||
| APACHE II score [every 1-point increase] | 1.05 | 1.00–1.11 | 0.07 | |||
| IMV time [every 1-h increase] | 1.03 | 1.02–1.05 | <0.001 | |||
| NPPV | 2.36 | 1.46–3.84 | <0.01 | 2.15 | 1.10–4.19 | <0.05 |
| CRRT | 3.81 | 1.20–12.1 | <0.05 | |||
| Delirium | 4.34 | 2.73–6.89 | <0.001 | 2.93 | 1.60–−5.37 | <0.01 |
| ICU stay (every 1-day increase) | 1.28 | 1.18–1.39 | <0.001 | |||
| Walking (every 1-day increase) | 1.37 | 1.23–1.54 | <0.001 | 1.29 | 1.07–1.56 | <0.01 |
APACHE, Acute Physiology and Chronic Health Evaluation; IMV, invasive mechanical ventilation; NPPV, noninvasive positive pressure ventilation; CRRT, continuous renal replacement therapy; ICU, intensive care unit.
Univariate and multivariate analyses for hospitalisation-associated disability by walking onset category.
| Univariate | Multivariate * | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Walking start category | ||||||
| Early | 1.00 | 1.00 | ||||
| Usual | 1.97 | 0.91–4.25 | 0.08 | 0.97 | 0.42–2.26 | 0.94 |
| Delayed | 9.55 | 4.45–20.52 | <0.001 | 2.76 | 1.05–7.21 | <0.05 |
* Adjusted for age, sex, albumin, haemoglobin, duration of ventilator intubation, APACHE II score, CRRT, NPPV, delirium, and length of stay in the ICU.